Your browser doesn't support javascript.
loading
Comparison of bypassing agents in patients on emicizumab using global hemostasis assays.
Kizilocak, Hande; Marquez-Casas, Elizabeth; Phei Wee, Choo; Malvar, Jemily; Carmona, Roxana; Young, Guy.
Afiliação
  • Kizilocak H; Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Marquez-Casas E; Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Phei Wee C; Saban Research Institute, Biostatistics Core, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Malvar J; Cancer and Blood Disease Institute, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Carmona R; Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, Los Angeles, CA, USA.
  • Young G; Hemostasis and Thrombosis Center, Children's Hospital Los Angeles, Los Angeles, CA, USA.
Haemophilia ; 27(1): 164-172, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33245833

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Hemofilia A Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Biespecíficos / Hemofilia A Idioma: En Ano de publicação: 2021 Tipo de documento: Article